MedTrace Logo

Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia

NCT01491412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 503

Last updated 2012-11-30

No results posted yet for this study

Summary

This is an observational study describing the real-life antipsychotic treatment during the hospitalisation of the patients due to acute psychotic episode.

In this NIS subject's data will be collected at one visit at the moment of discharge from the hospital.

The results of the study would help to characterise the discrepancy between current clinical practice and treatment guidelines, indicating that atypical antipsychotics are preferable and should be used in monotherapy during acute psychotic episodes in subjects with schizophrenia. Available evidence have revealed a frequent use of first-generation antipsychotics, polypharmacy, intramuscular route of administration and use of atypical antipsychotics in doses lower than recommended in registered summary of product characteristics.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Radu TEODORESCU, Prof. · Spitalul Clinic of Psychiatry named after Prof. Dr. Alexandru Obregia, Romania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Completion
2012-05-31

Countries

  • Hungary
  • Latvia
  • Romania

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01491412 on ClinicalTrials.gov